Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vactosertib + FOLFOX in Metastatic Pancreatic Cancer
NCT03666832Phase 2Unknown
- Start
- Jun 2019
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vactosertib in pancreatic adenocarcinoma (PDAC). Status: unknown.
02
Drugs
vactosertib
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT03666832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03666832.